ciglitazone has been researched along with epidermal growth factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, NS; Li, SF; Liu, JW; Pan, GD; Wu, H; Xiong, XZ; Yan, LN; Zhang, GF | 1 |
| Ansari, S; Bright, JJ; Chearwae, W; Gupta, SK; Kanakasabai, S; Pestereva, E | 1 |
2 other study(ies) available for ciglitazone and epidermal growth factor
| Article | Year |
|---|---|
Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.
Topics: Cells, Cultured; Cholecystitis; Epidermal Growth Factor; Epithelial Cells; Gallbladder; Humans; Inflammation; Interleukin-6; Interleukin-8; Ligands; Models, Biological; PPAR gamma; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2005 |
PPARĪ³ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes.
Topics: Animals; Antigens; Cell Differentiation; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Epidermal Growth Factor; Fibroblast Growth Factor 2; Gene Expression; Glial Fibrillary Acidic Protein; Intermediate Filament Proteins; Mice; Nerve Tissue Proteins; Nestin; Neural Stem Cells; Oligodendroglia; PPAR gamma; Prostaglandin D2; Proteoglycans; Thiazolidinediones; Tretinoin; Tubulin | 2012 |